Alefacept therapy for nephrogenic systemic fibrosis: A case series

Journal of Drugs in Dermatology

Volumn 10, Issue 8, 2011, Pages 922-924

  Robinson, Maria R ^a   Routhouska, Shannon B ^a   Paspulati, Raj M ^a   Korman, Neil J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; GADOLINIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CASE REPORT; CASE STUDY; CD4+ T LYMPHOCYTE; CONTRAST ENHANCEMENT; DEATH; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DUODENAL ULCER BLEEDING; FEMALE; FINGER; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; JOINT CONTRACTURE; JOINT MOBILITY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KNEE; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL DIALYSIS; PHYSIOTHERAPY; PSEUDOMONAS INFECTION; RANGE OF MOTION; SINUSITIS; SKIN BIOPSY; SKINFOLD THICKNESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; ULTRASOUND; WHEELCHAIR;

AGED; CONTRAST MEDIA; DERMATOLOGIC AGENTS; FEMALE; GADOLINIUM; HUMANS; MALE; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; RECOMBINANT FUSION PROTEINS; SKIN DISEASES;

EID: 80053086000     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. High WA, Ayers RA, Chandler J, et al. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2007;56:21-26. (Pubitemid 46017000)
2. Gilliet M, Cozzio A, Burg G, et al. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photoperesis. Br J Dermatol. 2005;208:278-280.
3. Kafi R, Fisher GJ, Quan T, et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol. 2004;140:1322-1324.
4. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478-483.
5. Wahba IM, White K, Meyer M, et al. The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy - report of two cases and review of the literature. Nephrol Dial Transplant. 2007;22:631-636. (Pubitemid 46189914)
6. Tran KT, Prather HB, Cockerell CJ, et al. UV-A1 therapy for nephrogenic systemic fibrosis. Arch Dermatol. 2009;145:1170-1174.145.
7. Kay J, High WA. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthririts Rheum. 2008; 58:2543-2548.
8. Bardin T, Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol. 2010 22;54-58.
9. Pizzimenti JJ, Daniel KP. Central serous chorioretinopathy after epidural steroid injection. Pharmacotherapy. 2005;25:1141-1146.
10. Swaminathan S, Arbiser JL, Hiatt KM, et al. Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phosph-70-ribosomal-S6 kinase. J Am Acad Dermatol. 2010;62:343-345
11. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema- like cutaneous disease in renal-dialysis patients. Lancet 2000;356:1000-1001.
12. DeHoratius DM, Cowper SE. Nephrogenic systemic fibrosis: an emerging threat among renal patients. Semin Dial. 2006;19:191- 194.
13. Swaminathan S, Ahmed I, McCarthy JT, et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med. 2006;145:234-235. (Pubitemid 46780577)
14. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 2003;25:358. (Pubitemid 36897345)
15. Moul D, Korman N. Alefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical use. Semin Cutan Med Surg. 2005;24:10-18. (Pubitemid 40410094)
16. Toor AA, Stiff PJ, Nickoloff BJ, et al. Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. J Dermatolog Treat. 2007;18:13-18. (Pubitemid 46410633)
17. Shapira MY, Adbul-Hai A, Resnick IB, et al. Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant. 2009;43:339-343.
18. Shapira MY, Resnick IB, Bitan M, et al. Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute GVHD. Bone Marrow Transplant. 2005;36:1097-1101.